NASDAQ: CLYMClimb Bio Inc Stock Ownership - Who owns Climb Bio?
Insider buying vs selling
Have Climb Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Aoife Brennan | President and CEO | 2026-06-29 | 30,902 | $13.17 | $406.98kSell |
| Stephen Basil Thomas | Director | 2026-02-26 | 16,313 | $7.01 | $114.29kSell |
| Stephen Basil Thomas | Director | 2026-02-25 | 33,687 | $7.01 | $235.98kSell |
| Stephen Basil Thomas | Director | 2026-02-13 | 10,000 | $5.81 | $58.14kSell |
| Stephen Basil Thomas | Director | 2026-02-12 | 90,000 | $5.23 | $470.97kSell |
| Ra Capital Management LP | Director | 2026-01-05 | 7,111 | $3.50 | $24.89kBuy |
| Ra Capital Management LP | Director | 2025-12-12 | 101,462 | $2.86 | $290.18kBuy |
| Ra Capital Management LP | Director | 2025-12-11 | 213,099 | $2.18 | $464.56kBuy |
CLYM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CLYM insiders and whales buy or sell their stock.
CLYM Shareholders
What type of owners hold Climb Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 19.74% | 11,300,939 | $141.94M | Institution |
| Ai Eti LLC | 8.75% | 5,009,400 | $62.92M | Insider |
| Mpm Bioimpact LLC | 4.53% | 2,593,439 | $32.57M | Institution |
| Price T Rowe Associates Inc | 3.35% | 1,916,968 | $24.08M | Institution |
| Braidwell LP | 2.67% | 1,529,675 | $19.21M | Institution |
| Great Point Partners LLC | 2.33% | 1,334,130 | $16.76M | Institution |
| Millennium Management LLC | 2.23% | 1,276,260 | $16.03M | Institution |
| Vanguard Capital Management LLC | 2.06% | 1,178,659 | $14.80M | Institution |
| Kynam Capital Management LP | 1.75% | 1,003,341 | $12.60M | Institution |
| Ra Capital Management LP | 1.47% | 841,087 | $10.56M | Insider |
CLYM vs Biotech Stocks
Climb Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.